Europe – ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage forms –...

ICH M13A Guideline is intended to provide recommendations on conducting bioequivalence (BE) studies during both development and post approval phases for orally administered immediate-release (IR) solid oral dosage forms...
Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Drug and medical device databases

This list of Health Canada's drug and medical device databases briefly describes the information available in each database. It does not provide an in...

UK – NICE endorses Neuraxpharm’s ublituximab for treating MS

Neuraxpharm Group has announced that the National Institute for Health and Care Excellence (NICE) has recommended ublituximab (BRIUMVI®) for the treatment of relapsing-remitting multiple...

UK – NICE recommends Immunocore’s Kimmtrak as first drug for aggressive eye cancer

Kimmtrak will now be available on the NHS in England to treat HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma, with more than 100...

USA – Researchers suggest FDA needs authority to require pediatric studies for orphan drugs

The US Food and Drug Administration (FDA) may need greater authority to require pediatric clinical studies for drugs, including orphan drugs, according to a...

USA – FDA finalizes BIMO electronic submission guidance

The US Food and Drug Administration (FDA) has finalized guidance for sponsors on electronically submitting data on drugs and biologics that the agency will...

USA – Accelerated approval: FDA revises guidance to reflect revised withdrawal procedures

The US Food and Drug Administration (FDA) on Thursday issued draft guidance that would replace the accelerated approval portion of its broader guidance covering...

Europe – Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2024

Doxycycline: currently available evidence not supporting link with risk of suicidality EMA’s safety committee (PRAC) has concluded that the currently available evidence is not sufficient...

USA – FDA recommends collecting ovarian toxicity data in cancer drug trials

The US Food and Drug Administration (FDA) is proposing sponsors collect ovarian toxicity data during cancer drug development. The agency said that cancer drugs...
Levothyrox : l’ANSM publie les dernières données issues de l’enquête de pharmacovigilance

France – Tramadol et codéine devront être prescrits sur une ordonnance sécurisée

Tramadol et codéine sont des médicaments opioïdes. Les risques de mésusage, de dépendance, d’abus et de surdosage qui leur sont associés sont importants. Afin...

NOS PROCHAINES FORMATIONS